Manipulation of apoptosis as a treatment modality in rheumatoid arthritis
Future Rheumatology · 2006
DOI: 10.2217/17460816.1.1.91 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Rheumatology, 2006. Verfasst von Maria Bokarewa und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 76 Literaturangaben.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is an inflammatory and destructive joint disease. Present treatment modalities although beneficial in approximately 40% of RA patients, are insufficient to prevent severe disability in a high number of nonresponders. Thus, new treatment approaches for RA are required. Apoptosis is programmed cell death. Insufficient apoptosis in the inflamed RA synovia leads to intra-articular accumulation of highly differentiated B and T lymphocytes and invasive growth of macrophages and fibroblasts. It might also prevent response to antirheumatic treatment. The intracellular events supporting long-term cell survival in RA include low sensitivity to the ligation of professional death receptors (Fas and tumor necrosis factor receptor) and the increase in caspase and mitochondrial activity inhibitors. The authors summarize the attempts to increase apoptosis in RA by stimulation through death receptors, targeting proteins of the inhibitor of apoptosis protein family and by using the inhibitors of t...
Zitieren
APA
Bokarewa, M., & Tarkowski, A. (2006). Manipulation of apoptosis as a treatment modality in rheumatoid arthritis. Future Rheumatology. https://doi.org/10.2217/17460816.1.1.91
Vancouver
Bokarewa M, Tarkowski A. Manipulation of apoptosis as a treatment modality in rheumatoid arthritis. Future Rheumatology. 2006. doi:10.2217/17460816.1.1.91
BibTeX
@article{Bokarewa2006,
author = {Bokarewa, Maria and Tarkowski, Andrej},
title = {Manipulation of apoptosis as a treatment modality in rheumatoid arthritis},
journal = {Future Rheumatology},
year = {2006},
doi = {10.2217/17460816.1.1.91}
}
EUVIMED